SHT is primarily recommended for women experiencing moderate to severe symptoms of menopause, such as hot flashes, night sweats, vaginal dryness, and mood swings. Additionally, it can be prescribed for younger women with premature ovarian insufficiency or those who have undergone surgical menopause. The therapy also plays a role in the prevention of osteoporosis in postmenopausal women.
